ASTRAZENECA WKN: 886455 ISIN: GB0009895292 Forum: Aktien Thema: Hauptdiskussion

Seit heute auch mit dabei.

👀👀

Warum nur?

-5%😲

https://www.deraktionaer.de/artikel/pharma-biotech/astrazeneca-aktie-dreht-auf-starke-zahlen-und-milliarden-deal-20336617.html

Wird wieder interessant hier ..

27 April 2023 Pascal Soriot, Chief Executive Officer, commenting on the results said: “AstraZeneca had a strong start to 2023, with Total Revenue excluding COVID-19 medicines increasing 15%. Our performance in Emerging Markets was particularly strong and I am impressed by the growth and pace of innovation I see in China, which underscores the competitive advantage of our leading presence in this country.”

https://endpts.com/astrazeneca-ionis-boast-full-phiii-win-for-attr-drug-under-review/

https://www.pharmatimes.com/news/astrazeneca_and_msds_lynparza_gets_green_light_1489951

https://www.lse.co.uk/news/top-news-astrazeneca-wins-three-approvals-in-eu-for-cancer-drugs-9xzz67maa167rty.html

https://www.cityam.com/drug-developer-files-patents-for-cancer-treatment-which-outperforms-astrazeneca-offering/

https://www.lse.co.uk/news/astrazeneca-notes-positive-phase-iii-analysis-for-heart-failure-drug-jcfm5grhtce2n4g.html

https://www.pmlive.com/pharma_news/astrazeneca_and_mederas_novoheart_develop_first_human_models_of_heart_failure_1480058?SQ_DESIGN_NAME=2&

https://www.benzinga.com/general/biotech/22/11/29495693/european-regulator-grants-complete-approval-to-astrazenecas-covid-19-vaccine

https://www.fiercepharma.com/marketing/long-last-astrazenecas-tremelimumab-snags-first-approval-only-ever-crowded-liver-cancer